HHC-P (hexahydrocannabiphorol) is a cannabinoid that occurs naturally in small quantities in the cannabis plant and is produced in nature primarily through various biological metabolic processes.
This happens in the cannabis plant itself, but also in the human body. For example, HHC-P is formed when cannabis products are heated, such as when smoked, or when exposed to an acidic environment, such as during digestion in our stomach.

HHC-P is produced industrially from its precursor CBD. Compared to HHC, it shows improved ability to bind to its associated receptors.

This means that, like its THC counterpart THC-P, it has stronger psychoactive properties than “normal” HHC.

Some of you probably already know HHC-P from the SuperStrong series from eighty8.

Δ9-Tetrahydrocannabutol, also called THC-B, is a homologue (very similar in chemical structure and mode of action) of classic THC and occurs naturally in the cannabis plant, albeit only in small quantities.
Commercially, it is obtained from CBD through the process of “Terpenylierum”.

Like THC, THC-B also interacts with the endocannabinoid system (ECS) in the body - a study by Italian researchers suggests that THC-B binds more strongly to CB1 than THC itself.

Furthermore, several research groups are currently focusing more on the anti-inflammatory and pain-relieving effects of this cannabinoid.

The effect of this cannabinoid is described by many users as very beneficial. It appears to produce a "softer" high than many other potent cannabinoids, despite its stronger binding to CB1. For this reason, it has recently been used more and more frequently specifically to combat anxiety and depression.

..Info coming soon..

..Info coming soon..

Infos coming soon